Search

everythinglearnresearchcommunity

for

Search:↓

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Early balding at 40 increases prostate cancer risk.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Finasteride doesn't harm bone density in older men with BPH.

Physical activity, height, and smoking affect prostate cancer risk.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Early hair loss may indicate prostate issues.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Finasteride may help reduce inappropriate sexual behaviors in dementia patients with prostate issues.

Saw palmetto can help with prostate issues and may promote hair growth.

Finasteride may reduce prostate bleeding by lowering blood vessel growth factor levels and blood vessel density in certain prostate areas.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Hair loss linked to prostate enlargement; stress and family history important factors.

Finasteride may improve prostate cancer treatment outcomes.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.